• 1. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8)

1-(2-Methylpropyl)piperazin-2-one, identified by the Chemical Abstracts Service Number (CAS No.) 893747-69-8, is a significant compound in the realm of chemical and pharmaceutical research. This piperazine derivative has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The compound features a piperazine ring substituted with a 2-methylpropyl group at the 1-position and a carbonyl group at the 2-position, which together contribute to its distinct reactivity and utility in synthetic pathways.

The molecular structure of 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) consists of a six-membered aromatic ring containing two nitrogen atoms, with one nitrogen bonded to a methylpropyl side chain and another to a carbonyl oxygen. This configuration imparts both steric hindrance and electronic effects that make the compound a versatile intermediate in organic synthesis. The presence of the carbonyl group further enhances its reactivity, allowing for further functionalization through condensation, oxidation, or reduction reactions.

In recent years, there has been growing interest in exploring the pharmacological properties of piperazine derivatives. The 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) structure has been investigated for its potential role in developing novel therapeutic agents. Piperazine-based compounds are known for their broad spectrum of biological activities, including antipsychotic, antihistaminic, and antimicrobial effects. The substitution pattern in 1-(2-Methylpropyl)piperazin-2-one may modulate these activities, making it a promising candidate for further pharmacological studies.

One of the most compelling aspects of 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) is its utility as a building block in drug discovery. Its structural features allow for easy modification at multiple sites, enabling chemists to tailor its properties for specific therapeutic targets. For instance, researchers have explored its use in synthesizing kinase inhibitors, where the piperazine moiety can interact with ATP-binding pockets in enzymes. Additionally, the compound’s ability to form hydrogen bonds due to the presence of nitrogen and oxygen atoms makes it an excellent scaffold for designing molecules with enhanced binding affinity.

Recent advancements in computational chemistry have also highlighted the potential of 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) as a lead compound. Molecular docking studies have shown that it can interact with various biological targets, including G-protein coupled receptors (GPCRs) and ion channels. These interactions are crucial for developing drugs that modulate neuronal signaling pathways, which are implicated in conditions such as depression, anxiety, and neurodegenerative disorders. The flexibility provided by the piperazine ring allows for precise tuning of binding interactions, making this compound a valuable asset in medicinal chemistry.

The synthesis of 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) involves multi-step organic reactions that highlight the compound’s synthetic versatility. Common synthetic routes include the condensation of 1-(2-methylpropyl)piperazine with ketones or aldehydes under acidic or basic conditions. These reactions often yield high yields and purity, making the compound readily accessible for further functionalization. Advanced techniques such as catalytic hydrogenation and cross-coupling reactions can also be employed to introduce additional substituents or modify existing ones.

In industrial applications, 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) serves as an intermediate in the production of fine chemicals and pharmaceuticals. Its stability under various reaction conditions makes it suitable for large-scale synthesis without significant degradation. Furthermore, its compatibility with green chemistry principles has led to efforts in developing more sustainable synthetic routes that minimize waste and energy consumption.

The pharmacokinetic profile of derivatives derived from 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) is another area of active research. By optimizing solubility, metabolic stability, and distribution properties, researchers aim to enhance drug bioavailability and reduce side effects. For example, prodrugs based on this scaffold have been investigated to improve oral absorption or targeted delivery to specific tissues.

Future directions in the study of 1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) may include exploring its role in emerging therapeutic areas such as immunomodulation and anti-inflammatory treatments. The piperazine core is known to interact with immune system components, suggesting potential applications in managing autoimmune diseases or infections. Additionally, nanotechnology-based delivery systems could be developed to enhance the efficacy of drugs derived from this compound.

In conclusion,1-(2-Methylpropyl)piperazin-2-one (CAS No. 893747-69-8) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features make it a valuable intermediate for synthesizing bioactive molecules targeting various diseases. As research continues to uncover new applications and synthetic strategies,1-(2-Methylpropyl)piperazin-2-one will likely remain at the forefront of medicinal chemistry innovation.

• 865875-76-9(1,5,8,12-Tetraazabicyclo[10.2.2]hexadecan-13-one)
• 148336-01-0(1-(cyclopropylmethyl)piperazin-2-one)
• 65464-10-0(1-Propylpiperazin-2-one)
• 191476-56-9(2,5-Piperazinedione,1-(cyclopropylmethyl)-4-methyl-)
• 400756-14-1(Piperazinone, 1-ethyl-6,6-dimethyl- (9CI))
• 208468-69-3(Acetamide,2-amino-N-methyl-N-(2-methylpropyl)-)
• 16350-84-8(2,5-Piperazinedione,1-(2-methylpropyl)-)
• 61533-52-6(2,6-Piperazinedione, 4,4'-(1,2-ethanediyl)bis[1-propyl-)
• 530160-08-8(1,4-bis(3-aminopropyl)-2-Piperazinone)
• 89433-47-6(N-Isobutyl-2-piperazin-1-ylacetamide)